Sorry, this entry is only available in Ukrainian and Russian.
Вас может заинтересовать:
COVID-19
Judging from trends in other countries, the next few weeks will be critical to ramp up production of essential testing kits and personal protection equipment (such as surgical masks and…
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…